These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 9102850

  • 1. [Guillain-Barre syndrome and antibodies to ganglioside GM1. Case report].
    Trisković I, Dimitrijević Lj, Rakocević-Stojanović V, Trikić R, Apostolski S.
    Srp Arh Celok Lek; 1996; 124(7-8):210-3. PubMed ID: 9102850
    [Abstract] [Full Text] [Related]

  • 2. [Clinical utility of measurement for anti-GM1 and anti-GQ1b antibodies].
    Tagawa Y, Matsumoto Y, Yuki N.
    No To Shinkei; 1998 Sep; 50(9):849-53. PubMed ID: 9789308
    [Abstract] [Full Text] [Related]

  • 3. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
    Gregson NA, Koblar S, Hughes RA.
    Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
    [Abstract] [Full Text] [Related]

  • 4. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection.
    Rees JH, Gregson NA, Hughes RA.
    Ann Neurol; 1995 Nov; 38(5):809-16. PubMed ID: 7486873
    [Abstract] [Full Text] [Related]

  • 5. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C, Vial C, Bancel J, Petiot P, Antoine JC, Gonnaud PM.
    Ann Biol Clin (Paris); 2002 Nov; 60(5):589-97. PubMed ID: 12368145
    [Abstract] [Full Text] [Related]

  • 6. The clinical correlates of high-titer IgG anti-GM1 antibodies.
    Kornberg AJ, Pestronk A, Bieser K, Ho TW, McKhann GM, Wu HS, Jiang Z.
    Ann Neurol; 1994 Feb; 35(2):234-7. PubMed ID: 8109905
    [Abstract] [Full Text] [Related]

  • 7. [Guillain-Barré syndrome with high titers of anti-GM2 and anti-GalNAc-GD1a antibody following cytomegalovirus hepatitis].
    Shimoya K, Ohnishi A, Hashimoto T, Yuki N.
    Rinsho Shinkeigaku; 1997 Feb; 37(2):106-10. PubMed ID: 9164140
    [Abstract] [Full Text] [Related]

  • 8. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis.
    Vriesendorp FJ, Mishu B, Blaser MJ, Koski CL.
    Ann Neurol; 1993 Aug; 34(2):130-5. PubMed ID: 8338337
    [Abstract] [Full Text] [Related]

  • 9. Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry.
    Oomes PG, Jacobs BC, Hazenberg MP, Bänffer JR, van der Meché FG.
    Ann Neurol; 1995 Aug; 38(2):170-5. PubMed ID: 7654064
    [Abstract] [Full Text] [Related]

  • 10. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome.
    Jacobs BC, van Doorn PA, Schmitz PI, Tio-Gillen AP, Herbrink P, Visser LH, Hooijkass H, van der Meché FG.
    Ann Neurol; 1996 Aug; 40(2):181-7. PubMed ID: 8773599
    [Abstract] [Full Text] [Related]

  • 11. GM1 antibody in Guillain-Barre syndrome after Campylobacter jejuni infection.
    Tang J, Yuan J, Hao H.
    Chin Med J (Engl); 1995 Apr; 108(4):262-4. PubMed ID: 7789212
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [A case of axonal form of Guillain-Barré syndrome associated with anti-GM1b IgG antibody following Penner 4 Campylobacter jejuni infection].
    Nagayama S, Kurohara K, Matsui M, Kuroda Y, Kusunoki S.
    Rinsho Shinkeigaku; 1997 Jun; 37(6):506-8. PubMed ID: 9366179
    [Abstract] [Full Text] [Related]

  • 16. [Pathogenesis of axonal Guillain-Barré syndrome].
    Yuki N.
    Rinsho Shinkeigaku; 2007 Jan; 47(1):1-7. PubMed ID: 17491330
    [Abstract] [Full Text] [Related]

  • 17. Axonal degeneration in the Guillain-Barré syndrome and anti-GM1 ganglioside antibodies.
    Yuki N, Sato S, Inuzuka T, Miyatake T, Yoshino H.
    Muscle Nerve; 1992 Jan; 15(1):116. PubMed ID: 1732757
    [No Abstract] [Full Text] [Related]

  • 18. Anti-GalNAc-GD1a antibody-associated Guillain-Barré syndrome with a predominantly distal weakness without cranial nerve impairment and sensory disturbance.
    Hao Q, Saida T, Yoshino H, Kuroki S, Nukina M, Saida K.
    Ann Neurol; 1999 Jun; 45(6):758-68. PubMed ID: 10360768
    [Abstract] [Full Text] [Related]

  • 19. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome.
    Yuki N, Susuki K, Koga M, Nishimoto Y, Odaka M, Hirata K, Taguchi K, Miyatake T, Furukawa K, Kobata T, Yamada M.
    Proc Natl Acad Sci U S A; 2004 Aug 03; 101(31):11404-9. PubMed ID: 15277677
    [Abstract] [Full Text] [Related]

  • 20. Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside.
    Yuki N, Yamada M, Koga M, Odaka M, Susuki K, Tagawa Y, Ueda S, Kasama T, Ohnishi A, Hayashi S, Takahashi H, Kamijo M, Hirata K.
    Ann Neurol; 2001 Jun 03; 49(6):712-20. PubMed ID: 11409422
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.